Complejo Hospitalario Universitario de Vigo

Vigo 36312

2 studies enrolling now · 5 studies all time

What they study most

Cardiovascular Diseases, Diabetes Mellitus, Type 2, Gastrointestinal Stromal Tumors, Hypertension, ICD Replacement or Upgrade, Inappropriate Shocks From Implanted Defibrillator, Interstitial Lung Diseases, Myocardial Infarction, Systemic Autoimmune Rheumatic Diseases Associated Interstitial Lung Diseases

Studies at this site

• EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease — Recruiting now
• A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases — Recruiting now
• A Study of Ripretinib vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib — Running, not enrolling
• EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction) — Completed
• Observational Study on Inappropriate Therapies — Status unconfirmed